Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual

Breast

Volumn 12, Issue 4, 2003, Pages 290-293

  Burcombe, R J ^a   Makris, Andreas ^a   Pittam, M ^b   Finer, N ^b  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

Androgens; Subcutaneous mastectomy; Trans sexual

Indexed keywords

ANDRACTIN; ANDROSTANOLONE; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; LUTEINIZING HORMONE; PROGESTERONE RECEPTOR; TAMOXIFEN; TESTOSTERONE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; ASPIRATION CYTOLOGY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; ENDOMETRIUM CANCER; ESTHETIC SURGERY; FAMILY HISTORY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; LYMPHADENECTOMY; MALE; MASTECTOMY; NIPPLE; PRIORITY JOURNAL; PROPHYLAXIS; REIMPLANTATION; SALPINGOOOPHORECTOMY; SUBCUTANEOUS MASTECTOMY; TRANSSEXUALISM; VIRILIZATION;

EID: 0042130370     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00033-X     Document Type: Article

References (23)

1. Dorgan J F et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996; 5(7): 533-539.
2. Berrino F et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88(5): 291-296.
3. Hankinson S E et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90(17): 1292-1299.
4. Veronesi U, Pizzocaro G. Breast cancer in women subsequent to cystic disease of the breast. Surg Gynecol Obstet 1968; 126(3): 529-532.
5. Secreto G et al. Increased androgenic activity and breast cancer risk in premenopausal women. Cancer Res 1984; 44(12 Pt 1): 5902-5905.
6. Yu H, Diamandis E P, Hoffman B. Elevated estradiol and testosterone levels and risk for breast cancer [letter; comment]. Ann Intern Med 1999; 131(9): 715.
7. Birrell S N, Hall R E, Tilley W D. Role of the androgen receptor in human breast cancer. J Mammary Gland Biol Neoplasia 1998; 3(1): 95-103.
8. Wang D Y et al. Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey. Br J Cancer 2000; 82(9): 1577-1584.
9. Cauley J A et al. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group [see comments]. Ann Intern Med 1999; 130(4 Pt 1): 270-277.
10. Symmers W S. Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with the primary and secondary sex characteristics. Br Med J 1968; 2(597): 82-85.
11. Ganly I, Taylor E W. Breast cancer in a trans-sexual man receiving hormone replacement therapy. Br J Surg 1995; 82(3): 341.
12. Conway A J et al. Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing [published erratum appears in Med J Aust 2000 Apr 3; 172(7): 334]. Med J Aust 2000; 172(5): 220-224.
13. Freeman B S, Wiemer D R. Total glandular mastectomy. Modifications of the subcutaneous mastectomy for use in premalignant disease of the breast. Plast Reconstr Surg 1978; 62(2): 167-172.
14. Eisen A et al. Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer. J Clin Oncol 2000; 18(9): 1980-1995.
15. Eldar S, Meguid M M, Beatty J D. Cancer of the breast after prophylactic subcutaneous mastectomy. Am J Surg 1984; 148(5): 692-693.
16. Goodnight J E Jr, Quagliana J M, Morton D L. Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 1984; 26(3): 198-201.
17. Ziegler L D, Kroll S S. Primary breast cancer after prophylactic mastectomy [clinical conference]. Am J Clin Oncol 1991; 14(5): 451-454.
18. Bowers D G Jr, Radlauer C B. Breast cancer after prophylactic subcutaneous mastectomies and reconstruction with silastic prostheses. Plast Reconstr Surg 1969; 44(6): 541-544.
19. Holleb A I, Montgomery R, Farrow J H. The hazard of incomplete simple mastectomy. Surg Gynecol Obstet 1965; 121(4): 819-822.
20. Hartmann L C et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer [see comments]. N Engl J Med 1999; 340(2): 77-84.
21. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet, 1998; 351(9114): 1451-1467.
22. Reed M J, Purohit A. Aromatase regulation and breast cancer. Clin Endocrinol (Oxford) 2001; 54(5): 563-571.
23. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1996; 348(9036): 1189-1196.